Pancreatic, thyroid, and other endocrine cancers:

Indications for LYSODREN:

Inoperable adrenal cortical carcinoma.


2–6g/day in divided doses (3–4 times/day). Doses may be increased incrementally to achieve a blood concentration of 14–20mg/L, or as tolerated. Dose modifications: see full labeling.


Not established.


Discontinue temporarily following shock or severe trauma. CNS toxicity (esp. with high doses). Adrenal insufficiency: give steroid replacement as clinically indicated; measure free cortisol and ACTH levels. Ovarian macrocysts in premenopausal women. Hepatic impairment. Pregnancy; avoid. Use effective contraception during and after discontinuation until mitotane levels are undetectable. Nursing mothers: not recommended.

Pharmacologic Class:

Adrenal cytotoxic agent.


Concomitant oral anticoagulants, CYP3A4 substrates; monitor for change in dose requirements.

Adverse Reactions:

Anorexia, nausea, vomiting, diarrhea, depression, dizziness, vertigo, rash, neutropenia, growth retardation, hypothyroidism, confusion, headache, ataxia, mental impairment, weakness, dysarthria, maculopathy, hepatitis, elevated liver enzymes, gynecomastia, hypercholesterolemia, hypertriglyceridemia.

How Supplied:


Pricing for LYSODREN

500mg tablet (Qty: 10)
Appx. price $60